Table 1.
Patients characteristics
| Characteristics | No deterioration n/N (%) | Deterioration n/N (%) | Total n/N (%) | |
|---|---|---|---|---|
| Age | ||||
| ≤18 years | 24/109 (22.02) | 10/38 (26.32) | 34/147 (23.13) | |
| >18 years | 85/109 (77.98) | 28/38 (73.68) | 113/147 (76.87) | |
| Sex | ||||
| Female | 60/107 (56.07) | 19/36 (52.78) | 79/143 (55.24) | |
| Male | 47/107 (43.93) | 17/36 (47.22) | 64/143 (44.76) | |
| Glasgow Coma Scale score1 | ||||
| 15 | 87/105 (82.86) | 18/36 (50.00) | 105/141 (74.47) | |
| 3–14 | 18/105 (17.14) | 18/36 (50.00) | 36/141 (25.53) | |
| Glasgow Coma Scale score | ||||
| >8 | 98/105 (93.33) | 30/36 (83.33) | 128/141 (90.78) | |
| ≤8 | 7/105 (6.67) | 6/36 (16.67) | 13/141 (9.22) | |
| Hemorrhage on initial head computed tomography | ||||
| Yes | 36/109 (33.03) | 18/38 (47.37) | 54/147 (36.73) | |
| No | 73/109 (66.97) | 20/38 (52.63) | 93/147 (63.27) | |
| Ischemic infarction on initial imaging | ||||
| Yes | 15/107 (14.02) | 10/38 (26.32) | 25/145 (17.24) | |
| No | 92/107 (85.98) | 28/38 (73.68) | 120/145 (82.76) | |
| Seizure activity1 | ||||
| Yes | 11/109 (10.09) | 10/38 (26.32) | 21/147 (14.29) | |
| No | 98/109 (89.91) | 28/38 (73.68) | 126/147 (85.71) | |
| Papilledema1 | ||||
| Yes | 7/109 (6.42) | 9/38 (23.68) | 16/147 (10.88) | |
| No | 102/109 (93.58) | 29/38 (76.32) | 131/147 (89.12) | |
| Location score (number of sinuses involved)1 | ||||
| >3 | 14/108 (12.96) | 13/37 (35.14) | 27/145 (18.62) | |
| ≤3 | 94/108 (87.04) | 24/37 (64.86) | 118/145 (81.38) | |
| Oral contraceptive pill use | ||||
| Yes | 11/109 (10.09) | 1/38 (2.63) | 12/147 (8.16) | |
| No | 98/109 (89.91) | 37/38 (97.37) | 135/147 (91.84) | |
| Mean age, years | 35.65 | 35.32 | 35.56 | |
| Mean sodium level, mEq/L | 140.28 | 138.71 | 139.88 | |
| Mean platelet count, ×109/L | 257.75 | 226.17 | 249.51 | |
1
Statistically significant according to the χ2 test for independence at the 5% significance level.